Cholangiocytes normally express primary cilia, a multisensory organelle that detects signals from the cellular environment. Cilia are significantly reduced in cholangiocarcinoma (CCA) by a mechanism involving overexpression of histone deacetylase 6 (HDAC6). Despite HDAC6 overexpression in CCA, we found no differences in its mRNA level, suggesting a posttranscriptional regulation, possibly involving microRNAs (miRNAs). Here, we describe that at least two HDAC6-targeting miRNAs, miR-433 and miR-22, are down-regulated in CCA both in vitro and in vivo. Experimental restoration of these miRNAs in CCA cells reduced HDAC6 expression, induced ciliary restoration, and decreased the malignant phenotype. Furthermore, in contrast to the mature forms, levels of precursor forms of these miRNAs were higher in CCA compared to normal cholangiocytes and accumulated in the nuclei, suggesting a defective nuclear export. We assessed the expression of Exportin-5, the protein responsible for transporting miRNA precursors out of the nucleus, and found it to be reduced by 50% in CCA compared to normal cholangiocytes. Experimental overexpression of Exportin-5 in CCA cells restored precursor and mature forms of these miRNAs to normal levels, inducing a decrease in the expression of HDAC6 and a decrease in the malignant phenotype. Conversely, short hairpin RNA (shRNA) depletion of Exportin-5 in normal cholangiocytes resulted in increased nuclear retention of precursor miRNAs, decreased mature miRNAs, increased cell proliferation, and shorter cilia. Conclusion: These data suggest that down-regulated Exportin-5 impairs the nuclear export of miR-433 and miR-22 precursor forms, causing a decrease in levels of mature miR-433 and miR-22 forms, and leading to overexpression of HDAC6 and ciliary loss in CCA. (HEPATOLOGY 2018; 68:561-573).
C holangiocarcinoma (CA) is a heterogeneous group of malignancies arising from cholangiocytes, the epithelial cells of the biliary tree. CCA has a poor prognosis and is difficult to diagnose in its early stages because of the absence of clinical manifestations. Over the past two decades, the incidence and mortality rates of CCA have increased worldwide. CCA accounts for 10%-20% of all Abbreviations: CCA, cholangiocarcinoma; cDNA, complementary DNA; DAPI, 4 0 ,6-diamino-2-phenylindole; HDAC6, histone-deacetylase-6; Hh, Hedgehog; IF, immunofluorescence; ISH, in situ hybridization; MAPK, mitogen-activated protein kinase; miRNA, microRNA; MTS, (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium); pre-miRNA, precursor form of miRNA; shRNA, short hairpin RNA; snRNAs, small noncoding RNAs; UTR, untranslated region.
hepatobiliary malignancies and is the second-most common primary hepatic cancer. (1) There is currently no effective chemoprevention or treatment for CCA; hence, surgical resection is the only prospect for long-term survival. ( 2) The 5-year survival rate is still as low as 10%, and therefore early detection or new targeted therapies are urgently needed. (3) The pathogenic pathways involved in the carcinogenesis of this biliary tumor are still unclear and may include alterations of several signaling cascades and molecules, such as histone deacetylase 6 (HDAC6). (4) (5) (6) (7) HDAC6 is a unique member of the HDAC family that is predominately localized in the cytoplasm. One of the main functions of HDAC6 is the deacetylation of atubulin, which is a cellular control mechanism for microtubule stability. (8, 9) Cholangiocytes have a single primary cilium, a microtubule-based organelle that extends from the apical membrane and functions as a mechano-, chemo-, and osmosensor. (10) (11) (12) (13) We recently found that primary cilia expression is decreased in CCA by a mechanism involving HDAC6 protein overexpression. (7) It is known that HDAC6 acts as a tubulin deacetylase, and the balance between deacetylation and acetylation serves as the molecular basis for stability and function of the ciliary axoneme. We found that the overexpression of HDAC6 is involved in primary cilia loss in CCA. However, the mechanisms of HDAC6 up-regulation remain unknown. Despite HDAC6 overexpression, we found that mRNA levels remain unaffected, which suggests a potential posttranscriptional regulation, likely microRNAs (miRNAs). (7) miRNAs are small noncoding RNAs (snRNAs) with an average length of 21 nucleotides (14) that are synthetized as precursor forms in the nucleus. The primary transcript is processed inside the nucleus to the precursor form (pre-miRNA) by the DroshaDiGeorge syndrome critical region gene 8 complex (also known as the Microprocessor complex). PremiRNAs are then translocated to the cytoplasm by Exportin-5 and further processed to generate the mature and functional miRNAs. The "seed" sequence (positions 2-7 from the 5 0 end of miRNAs) is complementary to the 3 0 UTR (untranslated region) of mRNA targets. miRNA complex interaction with mRNA induces posttranscriptional silencing through mRNA destabilization and/or translational repression. (15) Therefore, in the present work, we tested the hypothesis that decreasing levels of specific miRNAs induce overexpression of HDAC6 and ciliary loss in CCA.
Materials and Methods

CELL LINES AND CULTURE
Normal human cholangiocytes (H69 and NHC) were maintained as described. (7) The human CCA cell lines (HuCCT-1 and KMCH (16, 17) ) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY), 100 units/mL of penicillin, 100 ug/mL of streptomycin, and 100 ug/L of insulin at 378C in a humidified incubator containing 5% CO 2 .
TISSUE SAMPLES
The human specimens for immunofluorescences (normal human liver tissue and human CCA tissue) were obtained from the Mayo Center for Cell Signaling in Gastroenterology Clinical Core. For measuring miR-433 and miR-22 expression by real-time quantitative PCR (qPCR), tissues were obtained from normal human gallbladder (n 5 14) and CCA patients (tumor and matched surrounding tissue; n 5 19); these samples were provided by the Basque Biobank (http:// www.biobancovasco.org; Supporting Table S1 ) with approval from the Clinical Research Ethics Committee
of Donostia Hospital. Informed consent was obtained from all subjects.
QUANTITATIVE REVERSE PCR FOR miRNAs AND PRECURSOR miRNAs EXPRESSION (qRT-PCR)
Total RNA was performed by lysing cells in TRIzol reagent (Invitrogen, Carlsbad, CA), according to the supplier's instructions, and RNA concentration was determined using a Nanodrop ND-100 Spectrophotometer (Nanodrop, Wilmington, DE). qRT-PCR was applied to quantitate miR-22, miR-433, pri-miR-22, and pri-miR-433 expression in control and CCA cells. For mature miRNA, the TaqMan miRNA Reverse Transcription Kit and TaqMan hsa-miR-22 and hsamiR-433 primes and TM probes were used (all, Applied Biosystems). Precursor form expression was evaluated using SuperScript III First-Strand System for RT-PCR (Invitrogen, Waltham, MA) following the manufacturers' protocols. Briefly, 5 lg of total RNA was reverse transcribed to complementary DNA (cDNA) using random hexamer primers. cDNA was stored at -208C overnight and then used for qPCR. Reverse transcriptase was performed using the Veriti 96 well thermal cycler; qPCR was performed with TM fluorescent probes using the Light cycler 480 II (Roche, Indianapolis, IN). miRNA amounts were normalized to U6 snRNA and 18S snRNA for mature and precursor forms, respectively (Applied Biosystems, Foster City, CA). For nuclear pre-miRNA quantifications, nuclear RNA was extracted using the SurePrep Nuclear RNA purification kit (Fisher BioReagents, Fair Lawn, NJ) following the manufacturer's instructions. cDNA was synthesized using reverse transcriptase. pre-miRNAs were quantified by real-time PCR. U6 was used as an internal control. All reactions were performed in triplicate, and levels of gene expression were calculated using the 2 2DDCt method. Data are given as fold changes of average signals in normal and CCA cholangiocytes.
WESTERN BLOTTING
Protein fractions were subjected to 4%-20% sodium dodecyl sulfate/polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. After blocking, blottings were incubated overnight at 4 o C with HDAC6 (1:1,000; Santa Cruz Biotechnology, Dallas, TX), Exportin-5 (1:1,000; Santa Cruz Biotechology), actin (1:1,000; Sigma-Aldrich, St. Louis, MO), or acetylated a-tubulin (1:1,000; Sigma-Aldrich), washed, and incubated for 1 hour at room temperature with horseradish peroxidase-conjugated (1:5,000; Abcam, Cambridge, MA) corresponding secondary antibody. An enhanced chemiluminescence system was used for protein detection, and Gel-Pro Analyzer 6.0 software was used for densitometric analysis.
PROLIFERATION ASSAYS
Proliferation assays were conducted using the CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay
; Promega) and/or counting cells using the Cellometer Auto4 (Nexcelom Bioscience, Lawrence, MA) cell counter.
ANCHORAGE-INDEPENDENT GROWTH
Anchorage-independent growth was assessed by growing cells in soft agar. About 25,000 cells suspended in 0.4% agar in culture media were layered over a 1% agar layer in a six-well plate. Media was added twice a week, and pictures were taken after 14-21 days of incubation. The number and size of colonies were analyzed using Gel-Pro software.
COLONY FORMATION ASSAY
After 24-hour transfection with specific short hairpin RNAs (shRNAs), cells were seeded in six-well plates at 300 cells/well and cultured for 5 days. After fixation with methanol for 15 minutes, the colonies were stained with 0.1% crystal violet in 20% methanol. To quantify, the dye was dissolved with acetic acid solution (10%), and after 15 minutes, absorbance was measured at 450 nm.
WOUND HEALING ASSAY
Cells were cultured in complete medium at 378C in a humidified incubator maintained at an atmosphere of 5% CO 2 in six-well plates until cells were confluent. Cell monolayers were scratched using a 200-lL pipette tip, then rinsed three times with phosphate-buffered saline (PBS) to remove cell debris. Cell migration in the wound area was observed by phase-contrast microscopy at 0-8 hours and digitally photographed. Wound healing was measured on the images, and the migration area was calculated by the area of original wound minus the area of wound during healing using ImageJ software (NIH, Bethesda, MD).
CONFOCAL IMMUNOFLUORESCENCE MICROSCOPY
Confocal immunofluorescence (IF) microscopy was performed with a Zeiss LSM 510 confocal microscope using the 633 oil objective as described (see Supporting Methods). Briefly, unstained liver sections were deparaffinized and rehydrated, boiled in antigen unmasking solution, and quenched with Image-IT FX signal enhancer (Invitrogen, Grand Island, NY). Normal human cholangiocytes and CCA cells lines were washed with PBS and fixed in ice-cold methanol for 5 minutes at -208C. Slides were blocked for 1 hour at room temperature and then incubated overnight at 48C with acetylated a-tubulin (1:500; Sigma-Aldrich), c-tubulin (1:500; Sigma-Aldrich), and/or HDAC6 (1:100; Abcam) antibodies followed by 1-hour incubation with fluorescent secondary antibodies (1:100). Nuclei were stained with 4 0 ,6-diamino-2-phenylindole (DAPI; Prolong Gold w/DAPI; Invitrogen).
FLUORESCENCE IN SITU HYBRIDIZATION
Detection of miR-433 and miR-22 in formalinfixed, paraffin-embedded liver tissue was performed as described. (18) Briefly, tissues were deparaffinized, rehydrated, and subjected to heat-mediated antigen retrieval in 0.01 M of sodium citrate buffer (pH 6.0). Slides were allowed to cool, washed, and incubated in prehybridization solution (3% bovine serum albumin in 43 SSX) for 20 minutes at 548C. Tissues were then incubated for 1 hour at 548C with a fluorescein-labeled LNA probe to either miR-433 or miR-22 (Exiqon, Denmark) diluted to 25 nM in hybridization buffer (10% dextran sulfate in 43 SSC). Slides were washed and subjected to a tyramide signal amplification step (PerkinElmer, Waltham, MA), then washed again and mounted in Prolong Gold with DAPI (Thermo Fisher Scientific, Waltham, MA). Slides were analyzed on a Zeiss 710 Confocal Microscope.
STATISTICAL ANALYSIS
Data are expressed as the mean 6 SE. Experiments were repeated at least three times. Statistical analyses were performed using GraphPad Prism (version 5.0; GraphPad Software) and conducted by two-tailed Student t tests to compare two groups. A P value <0.05 was regarded as statistically significant.
Results
THE EXPRESSIONS OF miR-22 AND miR-433, BOTH TARGETING HDAC6, ARE DOWN-REGULATED IN CCA CELL LINES AND TISSUES
We have previously described that, despite HDAC6 protein overexpression in CCA, HDAC6 mRNA levels were not significantly different between normal and CCA cell lines, suggesting a posttranscriptional regulatory pathway. (7) To explore the role of miRNAs in this regulatory mechanism, we assessed in silico the potential miRNAs that could bind to HDAC6 mRNA. Using three different target prediction programs, 21 miRNAs were found to have a binding site in the 3 0 UTR of HDAC6 transcript (Supporting Table S2 ). Based on published data, two miRNAs, (19, 20) miR-22 and miR-433, were selected and their levels assessed in cells lines and clinical samples by qRT-PCR and in situ hybridization (ISH), respectively. miR-22 and miR-433 were down-regulated in both CCA cell lines, HuCCT-1 and KMCH, compared to normal cholangiocytes. Moreover, ISH revealed negative expression of miR-22 and miR-433 in CCA tissue when compared to controls (Fig. 1A) . Finally, an independent cohort of human CCA samples were analyzed by qPCR, and both miRNAs showed a statistically significant decrease when compared to matched surrounding tissue or gallbladder samples used as controls (Fig. 1B) . To confirm the regulation of HDAC6 by miRNAs, normal cholangiocytes were transfected with scrambled control, anti-miR-433, or miR-433 expression plasmids. As expected, miR-433 reduced and anti-miR-433 increased the levels of HDAC6 protein (Supporting Fig. S1A ). The 3 0 UTR region of HDAC6 was then cloned into a luciferase vector and cotransfected into normal cholangiocyte cells with miR-433 or scrambled control miRs. miR-433 reduced luciferase activity, consistent with HDAC6 regulation by miR-433 (Supporting Fig. S1B ). 433 and/or miR-22 in HuCCT-1 cells. As expected, overexpression of miR-433 induced down-regulation of HDAC6 in transfected cells compared to controls as observed by western blotting assays ( Fig. 2A,B) . Furthermore, overexpression of miR-433 or miR-22 decreased proliferation in this CCA cell line, with a slightly greater effect when overexpressed together (Fig. 2C) . Indeed, overexpression of miR-433 or miR-22 reduced the number of colonies formed by CCA cells, suggesting a decreased malignancy (Fig. 2D) . Furthermore, these miRNAs also reduced cellular migration (Fig. 2E) . Importantly, the experimental overexpression of miR-433 correlated with increased expression of primary cilia in CCA cells and decreased signaling in mitogen-activated protein kinase (MAPK) and Hedgehog (Hh) pathways, suggesting a less malignant phenotype (Fig.  2F,G) .
PRECURSOR FORMS OF miR-22 AND miR-433 ARE INCREASED IN CCA CELL LINES
To understand why these miRNAs are affected in CCA cell lines and human samples, we examined several factors involved in miRNA biogenesis. First, we studied the precursor forms of miR-22 (Pri-miR-22) and miR-433 (Pri-miR-433) by and to normal gallbladders as controls (*P < 0.05; ****P < 0.001).
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qRT-PCR. We found that, in contrast to the mature forms, pri-miR-22 and pri-miR-433 were up-regulated in the CCA cell lines, HuCCT-1 and KMCH, compared to normal control cholangiocytes (Fig. 3A) . Interestingly, ISH for miR-433 showed that the fluorescence signal was 
concentrated into the nucleus of CCA tissues compared to a more intense and predominantly cytoplasmic signal of normal bile duct samples (Figs. 1B and 3B). Taken together, these findings are suggestive of miRNA precursor forms being trapped in the nucleus. 
Exportin-5 IS DOWN-REGULATED BOTH IN VITRO AND IN VIVO
mRNA levels of genes involved in miRNA biosynthesis, such as Drosha, Dicer, and Exportin-5, were compared between normal and CCA cell lines, and only Exportin-5 was found to be significantly downregulated in CCA cells compared to normal cholangiocytes (Fig. 3C) . In addition, to confirm the expression of this miRNA shuttle, we performed western blottings in cell lines and IFs in both cell lines and human samples. Exportin-5 is decreased in CCA cell lines compared to normal cholangiocytes (Fig. 3D) . Consistently, IFs for Exportin-5 showed reduced signal in CCA cells and human samples compared to normal cholangiocytes and normal liver tissue, respectively ( Fig. 3E and Supporting Fig S2) . These results strongly suggest that the primary candidate responsible for impaired nuclear export of miRNA precursor forms is the down-regulation of Exportin-5.
EXPERIMENTAL OVEREXPRESSION OF Exportin-5 IN CCA CELLS RESTORED miRNA LEVELS AND REDUCED THE MALIGNANT PHENOTYPE
Having established the possible mechanism through which the precursor miRNAs are trapped in the nucleus, we sought to assess the effect of the experimental overexpression of Exportin-5 on tumor cells. Transfection of HuCCT-1 cells with an Exportin-5 expression plasmid demonstrated increased expression at protein levels by both western blotting and IF analyses (Fig. 4A,H) , allowing us to test miRNAs expression (mature and precursor miR-22 and miR-433) by qRT-PCR in those transfected cells. Overexpression of Exportin-5 induced a significant up-regulation of miR-22 and miR-433, whereas its precursor forms were significantly down-regulated (Fig. 4B) . To further test the hypothesis, we isolated RNA from nuclear fractions of HuCCT-1 control and Exportin-5-overexpressing cells and found that nuclear levels of miR-433 precursor forms were reduced upon Exportin-5 overexpression (Fig. 4C) , suggesting a more efficient export out of the nucleus. Next, we investigated the effect of Exportin-5 on tumor growth activity and found that overexpression of Exportin-5 decreased cell proliferation rate and reduced ability of colony formation (Fig. 4D,G) . Furthermore, we simultaneously transfected these cells with anti-miR-433 and anti-miR-22 to assess to what extent the beneficial effects of Exportin-5 overexpression were related to miR-433 and miR-22. Increased proliferation and cellular migration suggested that these effects are, at least in part, mediated by these two miRNAs (Fig. 4E,F) . Finally, western blotting analysis showed that overexpression of Exportin-5 induced a decrease in HDAC6 and down-regulated signaling on Hh and MAPK pathways (Fig. 4H) . Taken together, these findings suggest that the rescue of Exportin-5 allows the precursor miRNAs to reach the cytoplasm, where they are further processed to mature forms that regulate expression of HDAC6 and the malignant phenotype.
THE DOWN-REGULATION OF Exportin-5 IN NORMAL CELLS INDUCES SHORTER CILIA AND CELL PROLIFERATION
To further explore the role of Exportin-5 in miRNA dysregulation and cholangiocyte transformation, we down-regulated Exportin-5 in normal cholangiocyte cells by shRNA transfection. We found that downregulation of Exportin-5 induced shorter cilia as well as increased proliferation (Fig. 5A,B) . Furthermore, Exportin-5 down-regulation induced decreased levels of acetylated a-tubulin, suggesting increased activity of HDAC6 (Fig. 5C) . Importantly, down-regulation of Exportin-5 induced a decrease in miRNA-433 while increasing the levels of the precursor form (Fig. 5D) , and, consistent with a nuclear retention of the precursors, nuclear levels of miRNA precursor forms were significantly increased upon Exportin-5 knockdown (Fig. 5E ).
Discussion
The key findings reported here relate to the regulation of HDAC6 and ciliary expression by miRNAs and Exportin-5 in CCA cells. We found that: (1) at least two miRNAs (miR-22 and miR-433) targeting HDAC6 mRNA are down-regulated in CCA; (2) the experimental overexpression of miR-433 and/or miR-22 in CCA cells decreases HDAC6 protein levels, partially restores ciliogenesis, and induces reduction in the malignant phenotype (i.e., cell proliferation, anchorage independent growth, cellular migration, and MAPK and Hh signaling pathways); (3) precursor forms of miR-22 and miR-433 are up-regulated in CCA cell lines; (4) Exportin-5 is decreased in CCA; and (5) experimental overexpression of Exportin-5 increases miRNAs levels in the cytoplasm and decreases the precursor forms in the nuclear fraction, and induces reduction in malignancy phenotype whereas the opposite effects were observed when Exportin-5 was downregulated in normal cholangiocyte cells. The results of (D) Proliferation rates were measured by MTS assay (*P < 0.001; n 5 24). (E) Cellular migration assay (P < 0.05; n 5 3). (F) Anchorage independent growth was assessed by colony number formation in soft agar (*P < 0.0001; n 5 6). (G) The effect of XPO5 overexpression on levels of HDAC6, MAPK and Hh signaling was analyzed by western blottings (*P < 0.05; n 5 3). Abbreviations: Gli 1, glioma-associated oncogene homolog 1; p-ERK, phosphorylated extracellular signal-regulated kinase; t-ERK, total extracellular signal-regulated kinase.
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9 569 our study provide direct evidence that Exportin-5 is altered in CCA cells, promoting the accumulation of precursor forms of miR-433 and miR-22 and the subsequent down-regulation of mature forms and HDAC6 overexpression and ciliary loss.
We previously reported that HDAC6 is overexpressed in CCA, which induces the loss of primary cilia and promotes cholangiocyte malignancy. The loss of primary cilia dysregulates tumorigenic signaling pathways like MAPK and Hh. (7) Likewise, overexpression of HDAC6 has been reported in different types of tumors, such as breast cancer, melanoma, and pancreatic cancer. (21) (22) (23) Liu et al. found that HDAC6 was up-regulated in both melanoma cells and tissues compared to normal skin cells and tissues. (22) Indeed, HDAC6 knockdown in melanoma cells decreased cell growth and colonization. These findings are consistent with our results; however, the levels of HDAC6 mRNA are higher in melanoma cell lines than in normal skin cells. In contrast, we found unaffected levels of HDAC6 mRNA despite protein overexpression, suggesting a potential posttranscriptional regulation.
The study of the role of miRNAs and its dysregulation in the initiation and progression of cancer has become a very important subject. miRNAs regulate gene expression by binding to complementary target mRNAs and promoting their decay or inhibiting their translation. According to the role of their target genes, its aberrant expression functions as tumor suppressors or oncogenes. (24) There are several miRNAs dysregulated in CCA. (15, 25) Although the mechanisms by which different miRNAs modify CCA cells phenotype and tumor cells in general are well studied, the reasons for miRNAs alterations remain less known. Epigenetic alterations, DNA copy anomalies, transcriptional deregulations, and mutations might have roles in miRNA deregulation. (26) For instance, the treatment of HuCCT-1 cells with histone deacetylase inhibitor in combination with the DNA-demethylating agent, 5-aza-29-deoxycytidine, induces up-regulation of miR-376c. Based on this, Iwaki et al. suggested that miR-376c expression is suppressed by HDAC modification and DNA methylation. (27) He et al. reported that arsenic resistance protein 2 (Ars2), a protein involved in miRNA biogenesis, is overexpressed in biliary cancer. Depletion of Ars2 induces decreased expression of miR-21 and consequent reduction of cell proliferation and invasion rates. (28) Also, the regulatory region of miR-21 is inducible by interleukin-6/signal transducer and activator of transcription 3 and can be posttranscriptionally regulated by transforming growth factor beta and bone morphogenetic protein signaling. (29) The transcription factor, c-Myc, regulates around 10%-15% of the human genes, and it has been identified that c-Myc binds to the regulatory region of the miR-17-92 cluster. (30) Therefore, an increased expression of c-Myc might cause stimulation of the miRNAs in the cluster. (31, 32) As we described here, another mechanism involved in the dysregulation of miRNAs may be a defective nuclear/cytoplasmic transport by down-regulation of Exportin-5. In agreement with the described mechanism, Melo et al. showed that mutations in the Exportin-5 gene is another mechanism to explain deregulated miRNA expressions. (33, 34) Mutated XPO5 is mainly accumulated in the nucleus of colon-rectal cancer cell lines (HCT-15 and DLD-1) and leads to pre-miRNA being trapped in the nucleus. Our study also found that miRNA precursors are trapped in the nucleus, likely as a consequence of XPO5 downregulation in CCA cell lines. Whether XPO5 mutations, as suggested by TCGA database, epigenetic modifications, or other regulatory mechanisms, induce the down-regulation of Exportin-5 in CCA cells remains to be elucidated.
Interestingly, it has been recently reported that there are decreased levels of both mRNA and protein XPO5 in hepatocellular carcinoma (HCC) tissues compared to healthy control tissues in concordance with our findings in this small number of CCA human samples. (35) Additionally, a homozygous single-nucleotide polymorphism (SNP) site on the XPO5 gene in HCC, hepatocellular carcinoma patients showed shorter overall survival compared to both wild-type and heterozygous SNP genes. (36) Although there are no data about miRNA amounts in this study, based on other papers and in our own experiments, it is reasonable to assume that levels of mature miRNAs would decrease, inducing a more severe tumor phenotype. In our studies, we showed that recovering mature miRNAs by rescuing the expression of Exportin-5 have an antiproliferative effect and a reduced cell-anchorageindependent growth. Interestingly, our findings suggest that Exportin-5 may not be the only nuclear export mechanism available for miRNAs, at least in tumor cells. Even though the down-regulation of miRNAs is a common feature of tumors, which may be explained by a downregulation of Exportin-5, there are other miRNAs that are overexpressed. Indeed, consistent with our observations, mature miRNAs are markedly decreased in the cytoplasm and the precursor forms are accumulated in the nucleus of the colorectal cancer cell line, HCT116, with XPO5 knockout; however, a significant number of miRNAs are still produced in those cells. (37) On the other hand, consistent with our data, overexpression of XPO5 in HeLa cells led to an increase in mature miRNAs. (38) Interestingly, decreased expression of some miRNAs was described, suggesting that the biogenesis of miRNAs is a process that is individually and intricately regulated. Taken together, these results suggest that an alternative pathway to mediate nuclear translocation of pre-miRNAs may exist. In fact, miR-320, a noncanonical pre-miRNA, is exported by XPO1 and this shuttle involves exporting pri-miRNAs in Caenorhabditis elegans and Drosophila as well as mature miRNAs in mammals. (39) In summary, we found that mature forms of miR-22 and miR-433 are significantly decreased in CCA cell lines and human samples, whereas their precursor forms are trapped in the nucleus. Exportin-5 downregulation may be the underlying mechanism for this deregulation. We previously speculated that the loss of primary cilia by overexpression of HDAC6 in CCA induces disengagement between the environment and the cell interior and induces the derepression of tumorigenic pathways, and thereby proposed that the restoration of primary cilia would be a potential approach to decrease CCA progression. Here, we have further defined the mechanisms of ciliary loss by the dysregulation of miRNAs and identified potential targets, such as miR-22, miR-433, and Exportin-5, to reduce CCA cell growth (Supporting Fig S3) .
